Recent Updates
Recently added Catalysts
BAX Positive Sentiment

Baxter lanza el hemostático sellador HEMOPATCH, una almohadilla de colágeno para hemostasia y sellado "El hemostático sellador Hemopatch representa un avance significativo de Baxter, y la introducción de la versión a temperatura ambiente pone de...

Tuesday, May 20, 2025 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Baxter has launched HEMOPATCH, a collagen-based hemostatic sealant approved for hemostasis and sealing during open and minimally invasive surgeries. This new version can be stored at room temperature and boasts a shelf life of three years, marking a significant advancement in tissue management. Steve Wallace, president of Advanced Surgery at Baxter, emphasized the company's commitment to innovation.
Price reaction · baseline $31.47 (2025-05-19 close) · hit after-hours · clean, no other BAX news in the window
day 0 close
0%

Market Sentiment Analysis

POSITIVE FACTORS

  • Introduction of HEMOPATCH represents significant advancement.
  • New version allows for ambient temperature storage.
  • Prolonged shelf life of three years enhances usability.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+18%
120-day peak, hindsight
Typical move
1.9%
average across 12 past catalysts
Lead asset
Dianeal
Phase 3 · End Stage Renal Disease (ESRD)

Full Press Release Details

-Baxter lanza el hemostático sellador HEMOPATCH, una almohadilla de colágeno a temperatura ambiente aprobada para hemostasia y sellado, adecuada para cirugía abierta y procedimientos quirúrgicos mínimamente invasivos (MIS).
DEERFIELD, Ill. , 20 de mayo de 2025 /PRNewswire/ -- "El hemostático sellador Hemopatch representa un avance significativo de Baxter, y la introducción de la versión a temperatura ambiente pone de relieve nuestra dedicación continua a la innovación en el manejo de tejidos", afirmó Steve Wallace , presidente de Cirugía Avanzada de Baxter.
Tras una década de éxito en el mercado, Baxter se complace en presentar el hemostático sellador Hemopatch , que ahora ofrece la comodidad de almacenamiento a temperatura ambiente y una vida útil prolongada de 3 años.

Frequently Asked Questions

What is HEMOPATCH?

HEMOPATCH is a collagen-based hemostatic sealant approved for surgical use.

What are the storage requirements for HEMOPATCH?

The new version of HEMOPATCH can be stored at room temperature.

How long is the shelf life of HEMOPATCH?

HEMOPATCH has a shelf life of three years.

What types of surgeries can HEMOPATCH be used in?

HEMOPATCH is suitable for open surgeries and minimally invasive procedures.

ShareAdd on Google
Tags: BAX Viatris Investor Conferences Healthcare Baxter HEMOPATCH hemostatic sealant surgery collagen
Last updated: May 20, 2025

Biotech snapshot

Cash runway
$2151M liquidity · $0M/mo burn
Low dilution risk
Lead asset
DianealPhase 3
End Stage Renal Disease (ESRD) →

Catalyst track record

+18%
best trade around BAX's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for BAX.

See every catalyst's timing & PoA →